Life Sciences
Recent findings from AstraZeneca highlight research in life sciences
Published in Healthcare Finance, Tax and Law Weekly, February 25th, 2009
"The continued one-pot synthesis with 4 to a highly refined material like [5-C-14]-dimethylsulfanyltriazolepyridines 8 and 13 without any intermediate purification, six steps in the same pot from [C-14]KCN. Oxidation of the sulfur provided access to triazole-ethers upon reaction with alcohols," wrote P. Strom and colleagues, AstraZeneca.
The researchers concluded: "The triazole-ethers, 15, were obtained at fair to good yields and specific activities above 2 GBq/mmol."
Strom and colleagues...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- A.M. Best Company
A.M. Best Special Report: Recession, Reform and Competition Will Pressure Health Insurers’ Results - AARP
AARP Launches Government Watch Website to Hold Elected Leaders Accountable on Issues That Matter Most to Older Americans - AARP Illinois
AARP Survey Finds Middle-Aged & Older Americans Struggling in Economy - Abbott
Abbott Acquisition of Advanced Medical Optics Clears U.S. Antitrust Review - Acacia Research Corporation
Acacia Subsidiary Enters into License Agreement with Johnson & Johnson - Administaff, Inc.
Administaff Announces Results for Fourth Quarter and Full Year - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
